Introducing the PrisMax 2 System

The next-generation therapy system designed to help you meet the challenges of critical care with confidence.

PrisMax.png

Advancing what is possible in the ICU

As an evolution of the PrisMax platform, Baxter now launches the PrisMax 2 system built on feedback from healthcare professionals from all over the world. 

The new system takes extracorporeal therapies to the next level while it further improves user experience and optimizes efficiencies with wireless EMR connectivity – all to maximize confidence in therapy delivery in the ICU.

Welcome to the world of the PrisMax 2 system

Tell us about yourself

Doctor seen from the front  in a lab coat

I don’t have a Baxter CRRT system

Explore how the PrisMax 2 system might be the right choice for your ICU

existing prismaflex user

I have a Prismaflex system

Learn how you can get enhanced capabilities with a familiar system

PrisMax 2 machine in  view from the left side with therapy screen

I have a PrisMax system

Get access to all the benefits of the PrisMax 2 system with an easy upgrade to your current device

Meet the capabilities of the PrisMax 2 system

IMPORTANT SAFETY INFORMATION

The PrisMax control unit is intended for:
• Continuous Renal Replacement Therapy (CRRT) for patients with acute renal failure and/or fluid overload
• Therapeutic Plasma Exchange (TPE) therapy for patients with diseases where removal of plasma components is indicated
• Hemoperfusion (HP) for patients with conditions where immediate removal of substances by adsorption is indicated
• Extracorporeal CO2 Removal (ECCO2R) for patients with conditions where extracorporeal elimination of carbon dioxide is indicated

The Prismaflex control unit is intended for:
• Continuous Renal Replacement Therapy for patients with acute renal failure and/or fluid overload
• Therapeutic Plasma Exchange Therapy for patients with diseases where removal of plasma components is indicated
• Hemoperfusion for patients with conditions where immediate removal of substances by adsorption is indicated
• Hemopurification for patients with conditions where extracorporeal elimination of carbon dioxide is indicated

For safe and proper use of the products mentioned herein, please refer to the Operator’s Manual or Instructions for Use.